fanta.bio Sample: CNhs11789
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
19366 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 2398 / 18006 (13.3%) | 929 / 180060 (0.5%) | −324.0 | −324.0 | 25.81 |
| HIF1A SRX20663235 | HK-2 Kidney | 557 / 18006 (3.1%) | 254 / 180060 (0.1%) | −324.0 | −324.0 | 21.93 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1083 / 18006 (6.0%) | 502 / 180060 (0.3%) | −324.0 | −324.0 | 21.57 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1677 / 18006 (9.3%) | 856 / 180060 (0.5%) | −324.0 | −324.0 | 19.59 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2329 / 18006 (12.9%) | 1219 / 180060 (0.7%) | −324.0 | −324.0 | 19.11 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2386 / 18006 (13.3%) | 1250 / 180060 (0.7%) | −324.0 | −324.0 | 19.09 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1552 / 18006 (8.6%) | 885 / 180060 (0.5%) | −324.0 | −324.0 | 17.54 |
| SCML2 SRX644728 | 293 Kidney | 1401 / 18006 (7.8%) | 817 / 180060 (0.5%) | −324.0 | −324.0 | 17.15 |
| FOXP1 SRX736067 | LNCAP Prostate | 1893 / 18006 (10.5%) | 1186 / 180060 (0.7%) | −324.0 | −324.0 | 15.96 |
| MYH11 SRX265221 | ME-1 Blood | 835 / 18006 (4.6%) | 670 / 180060 (0.4%) | −324.0 | −324.0 | 12.46 |
| MED1 SRX9419944 | BT-474 Breast | 3570 / 18006 (19.8%) | 2917 / 180060 (1.6%) | −324.0 | −324.0 | 12.24 |
| MED1 SRX9419945 | BT-474 Breast | 3632 / 18006 (20.2%) | 2978 / 180060 (1.7%) | −324.0 | −324.0 | 12.20 |
| BRD4 SRX9419935 | BT-474 Breast | 3614 / 18006 (20.1%) | 2988 / 180060 (1.7%) | −324.0 | −324.0 | 12.10 |
| BRD4 SRX9419937 | BT-474 Breast | 3638 / 18006 (20.2%) | 3020 / 180060 (1.7%) | −324.0 | −324.0 | 12.05 |
| MED1 SRX9419947 | BT-474 Breast | 3672 / 18006 (20.4%) | 3050 / 180060 (1.7%) | −324.0 | −324.0 | 12.04 |
| BRD4 SRX9419936 | BT-474 Breast | 3697 / 18006 (20.5%) | 3143 / 180060 (1.7%) | −324.0 | −324.0 | 11.76 |
| BRD4 SRX9419938 | BT-474 Breast | 3659 / 18006 (20.3%) | 3148 / 180060 (1.7%) | −324.0 | −324.0 | 11.62 |
| MED1 SRX9419946 | BT-474 Breast | 3675 / 18006 (20.4%) | 3163 / 180060 (1.8%) | −324.0 | −324.0 | 11.62 |
| EZH2 SRX2146136 | LNCAP Prostate | 8247 / 18006 (45.8%) | 8460 / 180060 (4.7%) | −324.0 | −324.0 | 9.75 |
| BRD4 SRX736201 | 90-8TL Neural | 5937 / 18006 (33.0%) | 7297 / 180060 (4.1%) | −324.0 | −324.0 | 8.14 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1854 / 18006 (10.3%) | 2891 / 180060 (1.6%) | −324.0 | −324.0 | 6.41 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1796 / 18006 (10.0%) | 5264 / 180060 (2.9%) | −324.0 | −324.0 | 3.41 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 912 / 18006 (5.1%) | 26013 / 180060 (14.4%) | −324.0 | −324.0 | 0.35 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 887 / 18006 (4.9%) | 26229 / 180060 (14.6%) | −324.0 | −324.0 | 0.34 |
| PBX4 SRX2731658 | PC-3 Prostate | 773 / 18006 (4.3%) | 28628 / 180060 (15.9%) | −324.0 | −324.0 | 0.27 |
| FOS SRX150478 | MCF 10A Breast | 557 / 18006 (3.1%) | 21909 / 180060 (12.2%) | −324.0 | −324.0 | 0.25 |
| FOS SRX150477 | MCF 10A Breast | 515 / 18006 (2.9%) | 21419 / 180060 (11.9%) | −324.0 | −324.0 | 0.24 |
| FOS SRX4192880 | MCF 10A Breast | 402 / 18006 (2.2%) | 17410 / 180060 (9.7%) | −324.0 | −324.0 | 0.23 |
| YAP1 SRX757325 | H2052 Lung | 470 / 18006 (2.6%) | 22232 / 180060 (12.3%) | −324.0 | −324.0 | 0.21 |
| YAP1 SRX757326 | H2052 Lung | 407 / 18006 (2.3%) | 19872 / 180060 (11.0%) | −324.0 | −324.0 | 0.20 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 572 / 18006 (3.2%) | 20253 / 180060 (11.2%) | −322.6 | −319.6 | 0.28 |
| SS18 SRX3468047 | Fibroblasts Others | 669 / 18006 (3.7%) | 21720 / 180060 (12.1%) | −318.2 | −315.2 | 0.31 |
| GATA3 SRX190194 | SK-N-SH Neural | 634 / 18006 (3.5%) | 21000 / 180060 (11.7%) | −313.4 | −310.4 | 0.30 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 904 / 18006 (5.0%) | 25233 / 180060 (14.0%) | −312.9 | −309.9 | 0.36 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 638 / 18006 (3.5%) | 21018 / 180060 (11.7%) | −312.0 | −309.0 | 0.30 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 556 / 18006 (3.1%) | 19504 / 180060 (10.8%) | −306.9 | −303.9 | 0.29 |
| TCF12 SRX190356 | SK-N-SH Neural | 772 / 18006 (4.3%) | 22898 / 180060 (12.7%) | −303.7 | −300.8 | 0.34 |
| JUNB SRX8488073 | SUM 229PE Breast | 498 / 18006 (2.8%) | 18227 / 180060 (10.1%) | −297.4 | −294.4 | 0.27 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 825 / 18006 (4.6%) | 23503 / 180060 (13.1%) | −297.1 | −294.1 | 0.35 |
| JUN SRX17561461 | LPS141 Adipocyte | 353 / 18006 (2.0%) | 15581 / 180060 (8.7%) | −295.2 | −292.3 | 0.23 |
| SMARCA2 SRX8119677 | MeT-5A Others | 421 / 18006 (2.3%) | 16701 / 180060 (9.3%) | −291.3 | −288.4 | 0.25 |
| FOS SRX150517 | MCF 10A Breast | 456 / 18006 (2.5%) | 17302 / 180060 (9.6%) | −290.8 | −287.9 | 0.26 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 542 / 18006 (3.0%) | 18573 / 180060 (10.3%) | −284.5 | −281.6 | 0.29 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1025 / 18006 (5.7%) | 26054 / 180060 (14.5%) | −284.1 | −281.2 | 0.39 |
| FOS SRX150476 | MCF 10A Breast | 478 / 18006 (2.7%) | 17469 / 180060 (9.7%) | −283.7 | −280.9 | 0.27 |
| JUNB SRX8488088 | SUM 229PE Breast | 540 / 18006 (3.0%) | 18505 / 180060 (10.3%) | −283.3 | −280.5 | 0.29 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 718 / 18006 (4.0%) | 21274 / 180060 (11.8%) | −280.0 | −277.1 | 0.34 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 694 / 18006 (3.9%) | 20852 / 180060 (11.6%) | −278.6 | −275.7 | 0.33 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 427 / 18006 (2.4%) | 222 / 180060 (0.1%) | −276.1 | −273.2 | 19.23 |
| SMARCA4 SRX5212362 | Mel270 Others | 476 / 18006 (2.6%) | 17159 / 180060 (9.5%) | −274.8 | −272.0 | 0.28 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1134 / 18006 (6.3%) | 27231 / 180060 (15.1%) | −273.0 | −270.2 | 0.42 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 888 / 18006 (4.9%) | 23634 / 180060 (13.1%) | −272.7 | −269.9 | 0.38 |
| TP53 SRX19538279 | Osteoblasts Bone | 470 / 18006 (2.6%) | 329 / 180060 (0.2%) | −271.6 | −268.8 | 14.29 |
| JUN SRX6582171 | GM07492 Others | 557 / 18006 (3.1%) | 18345 / 180060 (10.2%) | −269.2 | −266.4 | 0.30 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 678 / 18006 (3.8%) | 20214 / 180060 (11.2%) | −266.7 | −264.0 | 0.34 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1237 / 18006 (6.9%) | 28445 / 180060 (15.8%) | −266.3 | −263.5 | 0.43 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 566 / 18006 (3.1%) | 18354 / 180060 (10.2%) | −264.9 | −262.1 | 0.31 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 566 / 18006 (3.1%) | 18340 / 180060 (10.2%) | −264.4 | −261.7 | 0.31 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 495 / 18006 (2.7%) | 17128 / 180060 (9.5%) | −263.3 | −260.6 | 0.29 |
| ESR1 SRX4367193 | MCF-7 Breast | 1037 / 18006 (5.8%) | 25364 / 180060 (14.1%) | −259.7 | −256.9 | 0.41 |
| FOXA1 SRX4815197 | MCF-7 Breast | 768 / 18006 (4.3%) | 21354 / 180060 (11.9%) | −259.0 | −256.3 | 0.36 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 364 / 18006 (2.0%) | 14713 / 180060 (8.2%) | −258.8 | −256.1 | 0.25 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 260 / 18006 (1.4%) | 12768 / 180060 (7.1%) | −258.7 | −256.0 | 0.20 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 778 / 18006 (4.3%) | 21440 / 180060 (11.9%) | −257.2 | −254.5 | 0.36 |
| PRRX1 SRX15235713 | Hs 578T Breast | 328 / 18006 (1.8%) | 13979 / 180060 (7.8%) | −256.1 | −253.4 | 0.23 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 519 / 18006 (2.9%) | 17279 / 180060 (9.6%) | −255.5 | −252.8 | 0.30 |
| JUN SRX883584 | MDA-MB-231 Breast | 457 / 18006 (2.5%) | 16200 / 180060 (9.0%) | −254.2 | −251.5 | 0.28 |
| SMARCA4 SRX5212357 | Mel270 Others | 413 / 18006 (2.3%) | 15417 / 180060 (8.6%) | −253.4 | −250.7 | 0.27 |
| TP53 SRX19538276 | U2OS Bone | 392 / 18006 (2.2%) | 205 / 180060 (0.1%) | −252.9 | −250.2 | 19.12 |
| MAU2 SRX15710550 | Fibroblasts Others | 480 / 18006 (2.7%) | 16543 / 180060 (9.2%) | −252.8 | −250.1 | 0.29 |
| SMARCA4 SRX5212366 | Mel270 Others | 378 / 18006 (2.1%) | 14767 / 180060 (8.2%) | −252.3 | −249.7 | 0.26 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 516 / 18006 (2.9%) | 17127 / 180060 (9.5%) | −252.3 | −249.6 | 0.30 |
| ESR1 SRX7624157 | MCF-7 Breast | 832 / 18006 (4.6%) | 22088 / 180060 (12.3%) | −252.2 | −249.6 | 0.38 |
| TP53 SRX19538274 | U2OS Bone | 392 / 18006 (2.2%) | 207 / 180060 (0.1%) | −252.1 | −249.4 | 18.94 |
| EP300 SRX2671813 | Fibroblasts Others | 198 / 18006 (1.1%) | 11320 / 180060 (6.3%) | −251.3 | −248.7 | 0.17 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 363 / 18006 (2.0%) | 14470 / 180060 (8.0%) | −251.3 | −248.6 | 0.25 |
| SMARCA4 SRX5212371 | Mel270 Others | 405 / 18006 (2.2%) | 15193 / 180060 (8.4%) | −250.7 | −248.1 | 0.27 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 516 / 18006 (2.9%) | 17010 / 180060 (9.4%) | −248.6 | −245.9 | 0.30 |
| AR SRX1067070 | LHSAR Prostate | 785 / 18006 (4.4%) | 21245 / 180060 (11.8%) | −248.3 | −245.7 | 0.37 |
| FOS SRX4192879 | MCF 10A Breast | 323 / 18006 (1.8%) | 13654 / 180060 (7.6%) | −248.2 | −245.6 | 0.24 |
| TP53 SRX19538268 | U2OS Bone | 384 / 18006 (2.1%) | 200 / 180060 (0.1%) | −248.1 | −245.5 | 19.20 |
| JUNB SRX8488074 | SUM 229PE Breast | 387 / 18006 (2.1%) | 14762 / 180060 (8.2%) | −247.0 | −244.4 | 0.26 |
| AR SRX1067071 | LHSAR Prostate | 618 / 18006 (3.4%) | 18600 / 180060 (10.3%) | −246.7 | −244.1 | 0.33 |
| PBX3 SRX190343 | SK-N-SH Neural | 665 / 18006 (3.7%) | 19334 / 180060 (10.7%) | −246.5 | −243.9 | 0.34 |
| GATA3 SRX190239 | MCF-7 Breast | 447 / 18006 (2.5%) | 15763 / 180060 (8.8%) | −245.7 | −243.1 | 0.28 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 411 / 18006 (2.3%) | 15133 / 180060 (8.4%) | −245.3 | −242.7 | 0.27 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 390 / 18006 (2.2%) | 14726 / 180060 (8.2%) | −243.9 | −241.4 | 0.26 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 248 / 18006 (1.4%) | 12052 / 180060 (6.7%) | −241.7 | −239.2 | 0.21 |
| FOXA1 SRX176862 | MCF-7 Breast | 406 / 18006 (2.3%) | 14928 / 180060 (8.3%) | −241.4 | −238.9 | 0.27 |
| FOXA1 SRX3931044 | MCF-7 Breast | 706 / 18006 (3.9%) | 19732 / 180060 (11.0%) | −239.4 | −236.9 | 0.36 |
| YAP1 SRX5718140 | 293 Kidney | 536 / 18006 (3.0%) | 17018 / 180060 (9.5%) | −238.6 | −236.0 | 0.31 |
| JUNB SRX10119386 | MCF 10A Breast | 247 / 18006 (1.4%) | 11913 / 180060 (6.6%) | −237.7 | −235.2 | 0.21 |
| FOXA1 SRX176863 | MCF-7 Breast | 371 / 18006 (2.1%) | 14196 / 180060 (7.9%) | −237.6 | −235.0 | 0.26 |
| JUN SRX6582172 | Fibroblasts Others | 391 / 18006 (2.2%) | 14547 / 180060 (8.1%) | −237.5 | −235.0 | 0.27 |
| NR3C1 SRX2609659 | HASM2 Lung | 338 / 18006 (1.9%) | 13560 / 180060 (7.5%) | −236.0 | −233.4 | 0.25 |
| ESR1 SRX371478 | MCF-7 Breast | 407 / 18006 (2.3%) | 14767 / 180060 (8.2%) | −235.7 | −233.1 | 0.28 |
| 5-mC SRX882970 | LNCAP Prostate | 3092 / 18006 (17.2%) | 16134 / 180060 (9.0%) | −234.1 | −231.6 | 1.92 |
| CEBPB SRX150632 | HeLa Uterus | 748 / 18006 (4.2%) | 20188 / 180060 (11.2%) | −234.0 | −231.5 | 0.37 |
| TP53 SRX19538275 | U2OS Bone | 362 / 18006 (2.0%) | 192 / 180060 (0.1%) | −232.4 | −229.9 | 18.85 |
| AGO2 SRX4708039 | Hep G2 Liver | 1922 / 18006 (10.7%) | 7981 / 180060 (4.4%) | −231.9 | −229.4 | 2.41 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 319 / 18006 (1.8%) | 13081 / 180060 (7.3%) | −231.5 | −228.9 | 0.24 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 284 / 18006 (1.6%) | 12432 / 180060 (6.9%) | −231.3 | −228.8 | 0.23 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 224 / 18006 (1.2%) | 11273 / 180060 (6.3%) | −231.1 | −228.6 | 0.20 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 217 / 18006 (1.2%) | 11090 / 180060 (6.2%) | −229.4 | −226.9 | 0.20 |
| 5-mC SRX882968 | LNCAP Prostate | 3055 / 18006 (17.0%) | 15984 / 180060 (8.9%) | −229.4 | −226.9 | 1.91 |
| JUND SRX190357 | SK-N-SH Neural | 390 / 18006 (2.2%) | 14253 / 180060 (7.9%) | −228.7 | −226.2 | 0.27 |
| FOSL2 SRX190296 | SK-N-SH Neural | 418 / 18006 (2.3%) | 14702 / 180060 (8.2%) | −227.7 | −225.2 | 0.28 |
| RUNX1 SRX2513054 | 293 Kidney | 3428 / 18006 (19.0%) | 18859 / 180060 (10.5%) | −227.4 | −224.9 | 1.82 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 475 / 18006 (2.6%) | 15649 / 180060 (8.7%) | −227.4 | −224.9 | 0.30 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 605 / 18006 (3.4%) | 17738 / 180060 (9.9%) | −227.0 | −224.6 | 0.34 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 417 / 18006 (2.3%) | 14621 / 180060 (8.1%) | −225.7 | −223.2 | 0.29 |
| ESR1 SRX7624156 | MCF-7 Breast | 535 / 18006 (3.0%) | 16570 / 180060 (9.2%) | −225.5 | −223.0 | 0.32 |
| FOXA1 SRX371482 | MCF-7 Breast | 483 / 18006 (2.7%) | 15715 / 180060 (8.7%) | −225.3 | −222.9 | 0.31 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 422 / 18006 (2.3%) | 14691 / 180060 (8.2%) | −225.2 | −222.7 | 0.29 |
| JUN SRX6582165 | BJ-5ta Epidermis | 638 / 18006 (3.5%) | 18158 / 180060 (10.1%) | −224.1 | −221.6 | 0.35 |
| JUNB SRX4192882 | MCF 10A Breast | 225 / 18006 (1.2%) | 11043 / 180060 (6.1%) | −222.4 | −219.9 | 0.20 |
| TP53 SRX19538267 | U2OS Bone | 341 / 18006 (1.9%) | 173 / 180060 (0.1%) | −222.3 | −219.8 | 19.71 |
| TP53 SRX19538280 | Osteoblasts Bone | 372 / 18006 (2.1%) | 246 / 180060 (0.1%) | −219.9 | −217.5 | 15.12 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 580 / 18006 (3.2%) | 17105 / 180060 (9.5%) | −219.9 | −217.4 | 0.34 |
| JUN SRX4192884 | MCF 10A Breast | 246 / 18006 (1.4%) | 11360 / 180060 (6.3%) | −219.2 | −216.8 | 0.22 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 588 / 18006 (3.3%) | 17191 / 180060 (9.5%) | −218.7 | −216.3 | 0.34 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 390 / 18006 (2.2%) | 13944 / 180060 (7.7%) | −218.7 | −216.3 | 0.28 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 645 / 18006 (3.6%) | 18079 / 180060 (10.0%) | −218.7 | −216.3 | 0.36 |
| TP53 SRX19538273 | U2OS Bone | 343 / 18006 (1.9%) | 186 / 180060 (0.1%) | −218.5 | −216.1 | 18.44 |
| JUN SRX6582163 | BJ-5ta Epidermis | 399 / 18006 (2.2%) | 14057 / 180060 (7.8%) | −217.5 | −215.1 | 0.28 |
| FOXA1 SRX1161177 | MCF-7 Breast | 333 / 18006 (1.8%) | 12890 / 180060 (7.2%) | −217.0 | −214.5 | 0.26 |
| NR3C1 SRX2609664 | HASM2 Lung | 460 / 18006 (2.6%) | 15063 / 180060 (8.4%) | −216.9 | −214.5 | 0.31 |
| ESR1 SRX371476 | MCF-7 Breast | 226 / 18006 (1.3%) | 10907 / 180060 (6.1%) | −216.9 | −214.5 | 0.21 |
| AR SRX10820653 | LNCAP Prostate | 352 / 18006 (2.0%) | 210 / 180060 (0.1%) | −216.6 | −214.2 | 16.76 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 415 / 18006 (2.3%) | 14300 / 180060 (7.9%) | −216.6 | −214.2 | 0.29 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 625 / 18006 (3.5%) | 1063 / 180060 (0.6%) | −216.3 | −213.9 | 5.88 |
| FOXL2 SRX6957431 | KGN Gonad | 795 / 18006 (4.4%) | 20254 / 180060 (11.2%) | −216.0 | −213.6 | 0.39 |
| ESR1 SRX176860 | MCF-7 Breast | 571 / 18006 (3.2%) | 16829 / 180060 (9.3%) | −215.9 | −213.5 | 0.34 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 276 / 18006 (1.5%) | 11821 / 180060 (6.6%) | −215.8 | −213.5 | 0.23 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 290 / 18006 (1.6%) | 12063 / 180060 (6.7%) | −215.3 | −212.9 | 0.24 |
| ESR1 SRX371469 | MCF-7 Breast | 350 / 18006 (1.9%) | 13137 / 180060 (7.3%) | −215.2 | −212.8 | 0.27 |
| NR3C1 SRX2609661 | HASM2 Lung | 353 / 18006 (2.0%) | 13110 / 180060 (7.3%) | −212.7 | −210.3 | 0.27 |
| ESR1 SRX20282961 | MCF-7 Breast | 437 / 18006 (2.4%) | 14543 / 180060 (8.1%) | −212.6 | −210.3 | 0.30 |
| FOXA1 SRX371481 | MCF-7 Breast | 361 / 18006 (2.0%) | 13228 / 180060 (7.3%) | −212.0 | −209.7 | 0.27 |
| GATA3 SRX176864 | MCF-7 Breast | 225 / 18006 (1.2%) | 10738 / 180060 (6.0%) | −211.8 | −209.5 | 0.21 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1219 / 18006 (6.8%) | 4007 / 180060 (2.2%) | −211.8 | −209.5 | 3.04 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 490 / 18006 (2.7%) | 15385 / 180060 (8.5%) | −211.7 | −209.3 | 0.32 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 481 / 18006 (2.7%) | 15231 / 180060 (8.5%) | −211.4 | −209.0 | 0.32 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 529 / 18006 (2.9%) | 15988 / 180060 (8.9%) | −210.9 | −208.5 | 0.33 |
| JUNB SRX8488089 | SUM 229PE Breast | 319 / 18006 (1.8%) | 12453 / 180060 (6.9%) | −210.8 | −208.4 | 0.26 |
| YAP1 SRX10119364 | MCF 10A Breast | 249 / 18006 (1.4%) | 11162 / 180060 (6.2%) | −210.6 | −208.2 | 0.22 |
| EP300 SRX2194265 | SUM 159PT Breast | 536 / 18006 (3.0%) | 16082 / 180060 (8.9%) | −210.3 | −207.9 | 0.33 |
| VGLL1 SRX24602130 | BT-20 Breast | 334 / 18006 (1.9%) | 12705 / 180060 (7.1%) | −210.3 | −207.9 | 0.26 |
| TLE3 SRX4815191 | MCF-7 Breast | 322 / 18006 (1.8%) | 12482 / 180060 (6.9%) | −210.0 | −207.7 | 0.26 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 599 / 18006 (3.3%) | 1002 / 180060 (0.6%) | −210.0 | −207.6 | 5.98 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 400 / 18006 (2.2%) | 13824 / 180060 (7.7%) | −209.6 | −207.2 | 0.29 |
| TP53 SRX19538281 | Osteoblasts Bone | 394 / 18006 (2.2%) | 333 / 180060 (0.2%) | −209.3 | −206.9 | 11.83 |
| FOXA1 SRX371483 | MCF-7 Breast | 394 / 18006 (2.2%) | 13701 / 180060 (7.6%) | −209.0 | −206.7 | 0.29 |
| ESR1 SRX371479 | MCF-7 Breast | 311 / 18006 (1.7%) | 12236 / 180060 (6.8%) | −208.4 | −206.0 | 0.25 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 513 / 18006 (2.8%) | 15598 / 180060 (8.7%) | −206.9 | −204.6 | 0.33 |
| JUNB SRX10119383 | MCF 10A Breast | 208 / 18006 (1.2%) | 10239 / 180060 (5.7%) | −206.1 | −203.7 | 0.20 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 641 / 18006 (3.6%) | 17562 / 180060 (9.8%) | −205.6 | −203.3 | 0.36 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 519 / 18006 (2.9%) | 15647 / 180060 (8.7%) | −205.5 | −203.1 | 0.33 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 451 / 18006 (2.5%) | 14512 / 180060 (8.1%) | −204.6 | −202.2 | 0.31 |
| JUN SRX7277180 | GM07492 Others | 259 / 18006 (1.4%) | 11146 / 180060 (6.2%) | −203.8 | −201.5 | 0.23 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 309 / 18006 (1.7%) | 12055 / 180060 (6.7%) | −203.7 | −201.4 | 0.26 |
| JUN SRX6582164 | BJ-5ta Epidermis | 427 / 18006 (2.4%) | 14068 / 180060 (7.8%) | −203.0 | −200.7 | 0.30 |
| IRF3 SRX11453858 | Hep G2 Liver | 284 / 18006 (1.6%) | 107 / 180060 (0.1%) | −202.7 | −200.4 | 26.54 |
| WWTR1 SRX10119367 | MCF 10A Breast | 392 / 18006 (2.2%) | 13462 / 180060 (7.5%) | −202.5 | −200.2 | 0.29 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2173 / 18006 (12.1%) | 10274 / 180060 (5.7%) | −202.3 | −200.0 | 2.12 |
| FOXA1 SRX371480 | MCF-7 Breast | 216 / 18006 (1.2%) | 10286 / 180060 (5.7%) | −202.3 | −200.0 | 0.21 |
| RELA SRX5938177 | FaDu Others | 295 / 18006 (1.6%) | 11752 / 180060 (6.5%) | −202.1 | −199.8 | 0.25 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1276 / 18006 (7.1%) | 26484 / 180060 (14.7%) | −202.0 | −199.7 | 0.48 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1479 / 18006 (8.2%) | 5697 / 180060 (3.2%) | −201.8 | −199.5 | 2.60 |
| ESR1 SRX176861 | MCF-7 Breast | 603 / 18006 (3.3%) | 16841 / 180060 (9.4%) | −201.7 | −199.5 | 0.36 |
| NR3C1 SRX2609665 | HASM2 Lung | 372 / 18006 (2.1%) | 13093 / 180060 (7.3%) | −201.7 | −199.4 | 0.28 |
| EP300 SRX2194266 | SUM 159PT Breast | 615 / 18006 (3.4%) | 17028 / 180060 (9.5%) | −201.7 | −199.4 | 0.36 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1278 / 18006 (7.1%) | 26466 / 180060 (14.7%) | −200.9 | −198.6 | 0.48 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 350 / 18006 (1.9%) | 12681 / 180060 (7.0%) | −200.7 | −198.4 | 0.28 |
| 5-mC SRX882965 | LNCAP Prostate | 2479 / 18006 (13.8%) | 12493 / 180060 (6.9%) | −200.4 | −198.1 | 1.98 |
| Epitope tags SRX10549776 | K-562 Blood | 1440 / 18006 (8.0%) | 5493 / 180060 (3.1%) | −199.3 | −197.1 | 2.62 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 308 / 18006 (1.7%) | 11888 / 180060 (6.6%) | −198.9 | −196.7 | 0.26 |
| JUNB SRX10119384 | MCF 10A Breast | 184 / 18006 (1.0%) | 9555 / 180060 (5.3%) | −198.8 | −196.5 | 0.19 |
| NR3C1 SRX2609662 | HASM2 Lung | 415 / 18006 (2.3%) | 13670 / 180060 (7.6%) | −197.0 | −194.7 | 0.30 |
| FOXA1 SRX1161176 | MCF-7 Breast | 342 / 18006 (1.9%) | 12422 / 180060 (6.9%) | −196.9 | −194.6 | 0.28 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 298 / 18006 (1.7%) | 11637 / 180060 (6.5%) | −196.5 | −194.2 | 0.26 |
| YAP1 SRX1038945 | IMR-90 Lung | 238 / 18006 (1.3%) | 10532 / 180060 (5.8%) | −196.4 | −194.1 | 0.23 |
| JUND SRX699738 | HCASMC Cardiovascular | 491 / 18006 (2.7%) | 14888 / 180060 (8.3%) | −196.3 | −194.0 | 0.33 |
| DAXX SRX1021630 | PC-3 Prostate | 345 / 18006 (1.9%) | 12435 / 180060 (6.9%) | −195.6 | −193.3 | 0.28 |
| TP53 SRX19538269 | U2OS Bone | 427 / 18006 (2.4%) | 481 / 180060 (0.3%) | −195.1 | −192.8 | 8.88 |
| FOXA1 SRX1161173 | MCF-7 Breast | 278 / 18006 (1.5%) | 11231 / 180060 (6.2%) | −195.0 | −192.7 | 0.25 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 329 / 18006 (1.8%) | 12129 / 180060 (6.7%) | −194.8 | −192.5 | 0.27 |
| FOXA1 SRX1161175 | MCF-7 Breast | 259 / 18006 (1.4%) | 10858 / 180060 (6.0%) | −194.2 | −191.9 | 0.24 |
| ESR1 SRX20282960 | MCF-7 Breast | 417 / 18006 (2.3%) | 13605 / 180060 (7.6%) | −194.1 | −191.8 | 0.31 |
| BRD4 SRX327751 | U-87 MG Neural | 1053 / 18006 (5.8%) | 23102 / 180060 (12.8%) | −193.7 | −191.4 | 0.46 |
| ESR1 SRX20282939 | MCF-7 Breast | 418 / 18006 (2.3%) | 13596 / 180060 (7.6%) | −193.2 | −190.9 | 0.31 |
| AR SRX10820651 | LNCAP Prostate | 372 / 18006 (2.1%) | 330 / 180060 (0.2%) | −193.0 | −190.8 | 11.27 |
| STAT3 SRX150479 | MCF 10A Breast | 320 / 18006 (1.8%) | 11917 / 180060 (6.6%) | −193.0 | −190.7 | 0.27 |
| STAT3 SRX2020842 | HCC70 Breast | 652 / 18006 (3.6%) | 17264 / 180060 (9.6%) | −192.4 | −190.1 | 0.38 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 557 / 18006 (3.1%) | 15803 / 180060 (8.8%) | −192.3 | −190.1 | 0.35 |
| ARID1A SRX5089376 | MCF-7 Breast | 299 / 18006 (1.7%) | 11502 / 180060 (6.4%) | −191.5 | −189.3 | 0.26 |
| GATA3 SRX5057632 | MCF-7 Breast | 218 / 18006 (1.2%) | 10002 / 180060 (5.6%) | −191.2 | −189.0 | 0.22 |
| FOS SRX070879 | HUVEC Cardiovascular | 370 / 18006 (2.1%) | 12719 / 180060 (7.1%) | −191.0 | −188.8 | 0.29 |
| JUN SRX2355072 | HAEC Cardiovascular | 472 / 18006 (2.6%) | 14402 / 180060 (8.0%) | −191.0 | −188.7 | 0.33 |
| STAT3 SRX150630 | MCF 10A Breast | 321 / 18006 (1.8%) | 11857 / 180060 (6.6%) | −190.6 | −188.3 | 0.27 |
| RNF2 SRX18954719 | SCC-25 Others | 486 / 18006 (2.7%) | 14605 / 180060 (8.1%) | −190.3 | −188.1 | 0.33 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1080 / 18006 (6.0%) | 23340 / 180060 (13.0%) | −190.3 | −188.0 | 0.46 |
| CEBPB SRX150598 | IMR-90 Lung | 758 / 18006 (4.2%) | 18741 / 180060 (10.4%) | −189.6 | −187.4 | 0.40 |
| ESR1 SRX371471 | ZR-75-1 Breast | 407 / 18006 (2.3%) | 13285 / 180060 (7.4%) | −189.3 | −187.1 | 0.31 |
| FOS SRX3322636 | MCF-7 Breast | 212 / 18006 (1.2%) | 9827 / 180060 (5.5%) | −189.3 | −187.1 | 0.22 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 479 / 18006 (2.7%) | 14445 / 180060 (8.0%) | −188.8 | −186.6 | 0.33 |
| RNF2 SRX18954704 | FaDu Others | 897 / 18006 (5.0%) | 20723 / 180060 (11.5%) | −188.8 | −186.6 | 0.43 |
| EP300 SRX150579 | HeLa Uterus | 216 / 18006 (1.2%) | 9887 / 180060 (5.5%) | −188.6 | −186.4 | 0.22 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 238 / 18006 (1.3%) | 10301 / 180060 (5.7%) | −188.6 | −186.4 | 0.23 |
| NR3C1 SRX2609666 | HASM2 Lung | 335 / 18006 (1.9%) | 12038 / 180060 (6.7%) | −188.5 | −186.3 | 0.28 |
| ARID1A SRX5679787 | 12Z Others | 108 / 18006 (0.6%) | 7661 / 180060 (4.3%) | −188.5 | −186.3 | 0.14 |
| FOXA1 SRX11222441 | MCF-7 Breast | 266 / 18006 (1.5%) | 10804 / 180060 (6.0%) | −188.2 | −186.0 | 0.25 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 250 / 18006 (1.4%) | 10508 / 180060 (5.8%) | −188.1 | −185.9 | 0.24 |
| FOXA1 SRX1787653 | MCF-7 Breast | 285 / 18006 (1.6%) | 11147 / 180060 (6.2%) | −188.1 | −185.9 | 0.26 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 272 / 18006 (1.5%) | 10872 / 180060 (6.0%) | −186.8 | −184.6 | 0.25 |
| NKX2-1 SRX2164786 | A549 Lung | 618 / 18006 (3.4%) | 16545 / 180060 (9.2%) | −186.7 | −184.5 | 0.37 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 831 / 18006 (4.6%) | 19696 / 180060 (10.9%) | −186.7 | −184.5 | 0.42 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 264 / 18006 (1.5%) | 10718 / 180060 (6.0%) | −186.6 | −184.4 | 0.25 |
| ESR1 SRX4367192 | MCF-7 Breast | 772 / 18006 (4.3%) | 18836 / 180060 (10.5%) | −186.6 | −184.4 | 0.41 |
| ESR1 SRX1531791 | MCF-7 Breast | 362 / 18006 (2.0%) | 12430 / 180060 (6.9%) | −186.3 | −184.2 | 0.29 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 233 / 18006 (1.3%) | 10129 / 180060 (5.6%) | −185.9 | −183.7 | 0.23 |
| Epitope tags SRX5877912 | U2OS Bone | 2177 / 18006 (12.1%) | 37291 / 180060 (20.7%) | −185.8 | −183.6 | 0.58 |
| TLE3 SRX4815194 | SUM 149PT Breast | 255 / 18006 (1.4%) | 10506 / 180060 (5.8%) | −185.1 | −182.9 | 0.24 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 528 / 18006 (2.9%) | 15083 / 180060 (8.4%) | −184.8 | −182.6 | 0.35 |
| ESR1 SRX371467 | MCF-7 Breast | 398 / 18006 (2.2%) | 12984 / 180060 (7.2%) | −184.6 | −182.5 | 0.31 |
| FOS SRX150664 | HUVEC Cardiovascular | 483 / 18006 (2.7%) | 14362 / 180060 (8.0%) | −184.5 | −182.3 | 0.34 |
| CEBPB SRX2194250 | SUM 159PT Breast | 444 / 18006 (2.5%) | 13728 / 180060 (7.6%) | −184.4 | −182.2 | 0.32 |
| RAC1 SRX10365541 | MCF-7 Breast | 179 / 18006 (1.0%) | 8996 / 180060 (5.0%) | −182.7 | −180.5 | 0.20 |
| ESR1 SRX20282972 | MCF-7 Breast | 423 / 18006 (2.3%) | 13326 / 180060 (7.4%) | −182.6 | −180.5 | 0.32 |
| FOXA1 SRX3923514 | MCF-7 Breast | 374 / 18006 (2.1%) | 12513 / 180060 (6.9%) | −182.5 | −180.4 | 0.30 |
| AR SRX1067067 | LHSAR Prostate | 646 / 18006 (3.6%) | 16815 / 180060 (9.3%) | −182.5 | −180.3 | 0.38 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 560 / 18006 (3.1%) | 1027 / 180060 (0.6%) | −182.2 | −180.0 | 5.45 |
| ARID1A SRX5679788 | 12Z Others | 129 / 18006 (0.7%) | 7945 / 180060 (4.4%) | −182.0 | −179.8 | 0.16 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 423 / 18006 (2.3%) | 13301 / 180060 (7.4%) | −181.8 | −179.6 | 0.32 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 478 / 18006 (2.7%) | 14174 / 180060 (7.9%) | −181.3 | −179.2 | 0.34 |
| ESR1 SRX20282954 | MCF-7 Breast | 416 / 18006 (2.3%) | 13163 / 180060 (7.3%) | −181.2 | −179.0 | 0.32 |
| WWTR1 SRX10119378 | MCF 10A Breast | 394 / 18006 (2.2%) | 12771 / 180060 (7.1%) | −180.3 | −178.2 | 0.31 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 480 / 18006 (2.7%) | 14162 / 180060 (7.9%) | −180.1 | −177.9 | 0.34 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1141 / 18006 (6.3%) | 23758 / 180060 (13.2%) | −180.0 | −177.9 | 0.48 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 251 / 18006 (1.4%) | 10279 / 180060 (5.7%) | −179.9 | −177.8 | 0.24 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 372 / 18006 (2.1%) | 12386 / 180060 (6.9%) | −179.7 | −177.6 | 0.30 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 263 / 18006 (1.5%) | 10479 / 180060 (5.8%) | −179.4 | −177.3 | 0.25 |
| FOSL2 SRX190204 | A549 Lung | 368 / 18006 (2.0%) | 12308 / 180060 (6.8%) | −179.4 | −177.3 | 0.30 |
| EP300 SRX100540 | SK-N-SH Neural | 559 / 18006 (3.1%) | 15376 / 180060 (8.5%) | −179.3 | −177.2 | 0.36 |
| FOXA1 SRX11222442 | MCF-7 Breast | 235 / 18006 (1.3%) | 9963 / 180060 (5.5%) | −179.2 | −177.1 | 0.24 |
| ESR1 SRX371470 | ZR-75-1 Breast | 358 / 18006 (2.0%) | 12109 / 180060 (6.7%) | −178.4 | −176.3 | 0.30 |
| JUN SRX2355073 | HAEC Cardiovascular | 473 / 18006 (2.6%) | 13989 / 180060 (7.8%) | −178.3 | −176.2 | 0.34 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 398 / 18006 (2.2%) | 12769 / 180060 (7.1%) | −178.3 | −176.1 | 0.31 |
| FOXA1 SRX11222437 | MCF-7 Breast | 261 / 18006 (1.4%) | 10401 / 180060 (5.8%) | −178.1 | −175.9 | 0.25 |
| NFIC SRX190336 | SK-N-SH Neural | 544 / 18006 (3.0%) | 15090 / 180060 (8.4%) | −177.8 | −175.6 | 0.36 |
| EP300 SRX10976215 | A549 Lung | 338 / 18006 (1.9%) | 11746 / 180060 (6.5%) | −177.8 | −175.6 | 0.29 |
| SP1 SRX190358 | HCT 116 Digestive tract | 593 / 18006 (3.3%) | 15837 / 180060 (8.8%) | −177.7 | −175.5 | 0.37 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 316 / 18006 (1.8%) | 11357 / 180060 (6.3%) | −177.4 | −175.3 | 0.28 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 265 / 18006 (1.5%) | 10450 / 180060 (5.8%) | −177.2 | −175.1 | 0.25 |
| RNF2 SRX18954702 | FaDu Others | 878 / 18006 (4.9%) | 19986 / 180060 (11.1%) | −176.9 | −174.8 | 0.44 |
| STAT3 SRX150536 | MCF 10A Breast | 421 / 18006 (2.3%) | 13100 / 180060 (7.3%) | −176.7 | −174.6 | 0.32 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 290 / 18006 (1.6%) | 10879 / 180060 (6.0%) | −176.7 | −174.6 | 0.27 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 419 / 18006 (2.3%) | 13056 / 180060 (7.3%) | −176.5 | −174.4 | 0.32 |
| ESR1 SRX10365536 | MCF-7 Breast | 194 / 18006 (1.1%) | 9092 / 180060 (5.0%) | −176.0 | −173.9 | 0.21 |
| ESR1 SRX194569 | MCF-7 Breast | 413 / 18006 (2.3%) | 12927 / 180060 (7.2%) | −175.6 | −173.5 | 0.32 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 165 / 18006 (0.9%) | 8508 / 180060 (4.7%) | −175.6 | −173.5 | 0.19 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 385 / 18006 (2.1%) | 12463 / 180060 (6.9%) | −175.4 | −173.3 | 0.31 |
| BRD4 SRX612504 | LX2 Liver | 153 / 18006 (0.8%) | 8258 / 180060 (4.6%) | −175.4 | −173.3 | 0.19 |
| AR SRX1067066 | LHSAR Prostate | 827 / 18006 (4.6%) | 19198 / 180060 (10.7%) | −175.2 | −173.1 | 0.43 |
| FOXA1 SRX1161174 | MCF-7 Breast | 394 / 18006 (2.2%) | 12601 / 180060 (7.0%) | −175.1 | −173.0 | 0.31 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 350 / 18006 (1.9%) | 11857 / 180060 (6.6%) | −174.9 | −172.8 | 0.30 |
| ARID1A SRX5089379 | MCF-7 Breast | 376 / 18006 (2.1%) | 12290 / 180060 (6.8%) | −174.8 | −172.7 | 0.31 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 266 / 18006 (1.5%) | 10382 / 180060 (5.8%) | −174.5 | −172.4 | 0.26 |
| MITF SRX7368256 | Hermes 3C Epidermis | 769 / 18006 (4.3%) | 18326 / 180060 (10.2%) | −174.4 | −172.3 | 0.42 |
| BRD4 SRX327752 | U-87 MG Neural | 701 / 18006 (3.9%) | 17323 / 180060 (9.6%) | −174.0 | −171.9 | 0.40 |
| SP1 SRX190269 | A549 Lung | 564 / 18006 (3.1%) | 15265 / 180060 (8.5%) | −174.0 | −171.9 | 0.37 |
| TLE3 SRX4815192 | MCF-7 Breast | 343 / 18006 (1.9%) | 11694 / 180060 (6.5%) | −173.6 | −171.5 | 0.29 |
| EP300 SRX190219 | SK-N-SH Neural | 377 / 18006 (2.1%) | 12236 / 180060 (6.8%) | −172.6 | −170.6 | 0.31 |
| TEAD1 SRX716558 | SF268 Neural | 169 / 18006 (0.9%) | 8491 / 180060 (4.7%) | −172.3 | −170.2 | 0.20 |
| FOXA1 SRX3931043 | MCF-7 Breast | 394 / 18006 (2.2%) | 12502 / 180060 (6.9%) | −172.2 | −170.1 | 0.32 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 491 / 18006 (2.7%) | 14052 / 180060 (7.8%) | −171.8 | −169.8 | 0.35 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 651 / 18006 (3.6%) | 16502 / 180060 (9.2%) | −171.8 | −169.7 | 0.39 |
| CIC SRX13262055 | Astrocytes Neural | 3075 / 18006 (17.1%) | 17806 / 180060 (9.9%) | −171.8 | −169.7 | 1.73 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1038 / 18006 (5.8%) | 21979 / 180060 (12.2%) | −170.9 | −168.9 | 0.47 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 463 / 18006 (2.6%) | 13574 / 180060 (7.5%) | −170.8 | −168.7 | 0.34 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 423 / 18006 (2.3%) | 12928 / 180060 (7.2%) | −170.7 | −168.7 | 0.33 |
| JUND SRX150408 | HeLa Uterus | 336 / 18006 (1.9%) | 11484 / 180060 (6.4%) | −170.6 | −168.6 | 0.29 |
| ESR1 SRX371477 | MCF-7 Breast | 180 / 18006 (1.0%) | 8654 / 180060 (4.8%) | −170.3 | −168.3 | 0.21 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 362 / 18006 (2.0%) | 11896 / 180060 (6.6%) | −169.9 | −167.8 | 0.30 |
| ESR1 SRX371468 | MCF-7 Breast | 254 / 18006 (1.4%) | 10011 / 180060 (5.6%) | −169.4 | −167.3 | 0.25 |
| KAT6A SRX20971022 | Fibroblasts Others | 241 / 18006 (1.3%) | 96 / 180060 (0.1%) | −169.4 | −167.3 | 25.10 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 369 / 18006 (2.0%) | 11993 / 180060 (6.7%) | −169.3 | −167.2 | 0.31 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 229 / 18006 (1.3%) | 9547 / 180060 (5.3%) | −169.3 | −167.2 | 0.24 |
| HOXC5 SRX2731653 | PC-3 Prostate | 299 / 18006 (1.7%) | 10798 / 180060 (6.0%) | −169.1 | −167.1 | 0.28 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 259 / 18006 (1.4%) | 131 / 180060 (0.1%) | −169.0 | −167.0 | 19.77 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 452 / 18006 (2.5%) | 695 / 180060 (0.4%) | −168.6 | −166.6 | 6.50 |
| TEAD1 SRX3401272 | MCF-7 Breast | 289 / 18006 (1.6%) | 10605 / 180060 (5.9%) | −168.6 | −166.5 | 0.27 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 370 / 18006 (2.1%) | 11983 / 180060 (6.7%) | −168.6 | −166.5 | 0.31 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 638 / 18006 (3.5%) | 16183 / 180060 (9.0%) | −168.5 | −166.4 | 0.39 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 552 / 18006 (3.1%) | 14872 / 180060 (8.3%) | −168.2 | −166.2 | 0.37 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1774 / 18006 (9.9%) | 8271 / 180060 (4.6%) | −168.1 | −166.1 | 2.14 |
| FOXA1 SRX3931055 | MCF-7 Breast | 324 / 18006 (1.8%) | 11194 / 180060 (6.2%) | −168.0 | −166.0 | 0.29 |
| JUNB SRX10119385 | MCF 10A Breast | 161 / 18006 (0.9%) | 8209 / 180060 (4.6%) | −167.9 | −165.9 | 0.20 |
| ESR1 SRX20282973 | MCF-7 Breast | 481 / 18006 (2.7%) | 13746 / 180060 (7.6%) | −167.6 | −165.6 | 0.35 |
| RAC1 SRX10365543 | MCF-7 Breast | 204 / 18006 (1.1%) | 9034 / 180060 (5.0%) | −167.6 | −165.6 | 0.23 |
| FOXA1 SRX1787652 | MCF-7 Breast | 226 / 18006 (1.3%) | 9440 / 180060 (5.2%) | −167.6 | −165.5 | 0.24 |
| TP53 SRX19538270 | U2OS Bone | 389 / 18006 (2.2%) | 485 / 180060 (0.3%) | −167.2 | −165.1 | 8.02 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 236 / 18006 (1.3%) | 9607 / 180060 (5.3%) | −167.0 | −165.0 | 0.25 |
| ARID5B SRX3230377 | Hep G2 Liver | 1002 / 18006 (5.6%) | 21318 / 180060 (11.8%) | −166.9 | −164.9 | 0.47 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 256 / 18006 (1.4%) | 9959 / 180060 (5.5%) | −166.6 | −164.6 | 0.26 |
| CEBPB SRX2194249 | SUM 159PT Breast | 385 / 18006 (2.1%) | 12158 / 180060 (6.8%) | −166.3 | −164.3 | 0.32 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 234 / 18006 (1.3%) | 9546 / 180060 (5.3%) | −166.2 | −164.2 | 0.25 |
| TEAD4 SRX10640863 | SK-MEL-147 Epidermis | 537 / 18006 (3.0%) | 14566 / 180060 (8.1%) | −166.1 | −164.1 | 0.37 |
| RNF2 SRX18954706 | SCC-25 Others | 485 / 18006 (2.7%) | 13752 / 180060 (7.6%) | −166.0 | −164.0 | 0.35 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 281 / 18006 (1.6%) | 10370 / 180060 (5.8%) | −165.6 | −163.6 | 0.27 |
| FOXA1 SRX3931054 | MCF-7 Breast | 369 / 18006 (2.0%) | 11864 / 180060 (6.6%) | −165.3 | −163.3 | 0.31 |
| ESR1 SRX2943591 | MCF-7 Breast | 275 / 18006 (1.5%) | 10245 / 180060 (5.7%) | −165.0 | −163.0 | 0.27 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 511 / 18006 (2.8%) | 14122 / 180060 (7.8%) | −165.0 | −163.0 | 0.36 |
| ESR1 SRX194572 | MCF-7 Breast | 259 / 18006 (1.4%) | 9961 / 180060 (5.5%) | −165.0 | −163.0 | 0.26 |
| ARID1A SRX5089385 | MCF-7 Breast | 283 / 18006 (1.6%) | 10382 / 180060 (5.8%) | −164.9 | −162.9 | 0.27 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 564 / 18006 (3.1%) | 14934 / 180060 (8.3%) | −164.9 | −162.9 | 0.38 |
| FOXA1 SRX1447317 | MCF-7 Breast | 246 / 18006 (1.4%) | 9722 / 180060 (5.4%) | −164.9 | −162.8 | 0.25 |
| Epitope tags SRX5877914 | U2OS Bone | 2232 / 18006 (12.4%) | 36940 / 180060 (20.5%) | −164.8 | −162.8 | 0.60 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 531 / 18006 (2.9%) | 1030 / 180060 (0.6%) | −164.6 | −162.6 | 5.16 |
| ESR1 SRX10365535 | MCF-7 Breast | 328 / 18006 (1.8%) | 11141 / 180060 (6.2%) | −164.3 | −162.3 | 0.29 |
| RELA SRX7055007 | HAEC Cardiovascular | 728 / 18006 (4.0%) | 17342 / 180060 (9.6%) | −164.2 | −162.2 | 0.42 |
| WWTR1 SRX10119368 | MCF 10A Breast | 267 / 18006 (1.5%) | 10070 / 180060 (5.6%) | −164.0 | −162.0 | 0.27 |
| EP300 SRX176885 | MCF-7 Breast | 193 / 18006 (1.1%) | 8710 / 180060 (4.8%) | −163.9 | −161.9 | 0.22 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 241 / 18006 (1.3%) | 9601 / 180060 (5.3%) | −163.8 | −161.8 | 0.25 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 337 / 18006 (1.9%) | 11274 / 180060 (6.3%) | −163.8 | −161.8 | 0.30 |
| FOXA1 SRX100454 | T-47D Breast | 534 / 18006 (3.0%) | 14426 / 180060 (8.0%) | −163.6 | −161.6 | 0.37 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 438 / 18006 (2.4%) | 12919 / 180060 (7.2%) | −163.5 | −161.4 | 0.34 |
| GATA3 SRX5457550 | MCF-7 Breast | 452 / 18006 (2.5%) | 13130 / 180060 (7.3%) | −163.1 | −161.1 | 0.34 |
| FOXA1 SRX1787655 | MCF-7 Breast | 188 / 18006 (1.0%) | 8589 / 180060 (4.8%) | −163.0 | −161.0 | 0.22 |
| PRMT1 SRX3642947 | Keratinocytes Epidermis | 221 / 18006 (1.2%) | 9205 / 180060 (5.1%) | −162.8 | −160.8 | 0.24 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 335 / 18006 (1.9%) | 11196 / 180060 (6.2%) | −162.4 | −160.4 | 0.30 |
| FOS SRX3322637 | MCF-7 Breast | 198 / 18006 (1.1%) | 8761 / 180060 (4.9%) | −162.4 | −160.4 | 0.23 |
| NR3C1 SRX10976921 | A549 Lung | 273 / 18006 (1.5%) | 10122 / 180060 (5.6%) | −162.2 | −160.2 | 0.27 |
| MYC SRX150570 | MCF 10A Breast | 255 / 18006 (1.4%) | 9795 / 180060 (5.4%) | −162.0 | −160.0 | 0.26 |
| TP53 SRX19538282 | Osteoblasts Bone | 340 / 18006 (1.9%) | 356 / 180060 (0.2%) | −161.9 | −159.9 | 9.55 |
| FOXA1 SRX3923518 | MCF-7 Breast | 268 / 18006 (1.5%) | 10016 / 180060 (5.6%) | −161.7 | −159.7 | 0.27 |
| EP300 SRX10976625 | A549 Lung | 218 / 18006 (1.2%) | 9088 / 180060 (5.0%) | −160.8 | −158.8 | 0.24 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 190 / 18006 (1.1%) | 8552 / 180060 (4.7%) | −160.5 | −158.5 | 0.22 |
| IRF3 SRX11453861 | Hep G2 Liver | 239 / 18006 (1.3%) | 111 / 180060 (0.1%) | −160.4 | −158.4 | 21.53 |
| FOXA1 SRX028634 | MCF-7 Breast | 190 / 18006 (1.1%) | 8545 / 180060 (4.7%) | −160.2 | −158.2 | 0.22 |
| FOXA1 SRX1787651 | MCF-7 Breast | 220 / 18006 (1.2%) | 9099 / 180060 (5.1%) | −160.1 | −158.1 | 0.24 |
| FOXA1 SRX13814018 | 5637 Others | 243 / 18006 (1.3%) | 9509 / 180060 (5.3%) | −159.7 | −157.7 | 0.26 |
| FOXL2 SRX6957477 | KGN Gonad | 418 / 18006 (2.3%) | 12469 / 180060 (6.9%) | −159.6 | −157.7 | 0.34 |
| FOXA1 SRX3923517 | MCF-7 Breast | 282 / 18006 (1.6%) | 10195 / 180060 (5.7%) | −159.6 | −157.6 | 0.28 |
| NR3C1 SRX17639412 | A549 Lung | 454 / 18006 (2.5%) | 13039 / 180060 (7.2%) | −159.6 | −157.6 | 0.35 |
| FOSL1 SRX17608312 | T24 Others | 139 / 18006 (0.8%) | 7522 / 180060 (4.2%) | −159.5 | −157.6 | 0.18 |
| CEBPB SRX190345 | MCF-7 Breast | 310 / 18006 (1.7%) | 10670 / 180060 (5.9%) | −159.4 | −157.4 | 0.29 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 328 / 18006 (1.8%) | 10977 / 180060 (6.1%) | −159.4 | −157.4 | 0.30 |
| FOXA1 SRX5323843 | MCF-7 Breast | 200 / 18006 (1.1%) | 8705 / 180060 (4.8%) | −159.3 | −157.4 | 0.23 |
| TRP47 SRX4548329 | THP-1 Blood | 2622 / 18006 (14.6%) | 14695 / 180060 (8.2%) | −159.2 | −157.3 | 1.78 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 386 / 18006 (2.1%) | 11933 / 180060 (6.6%) | −159.2 | −157.2 | 0.32 |
| SMAD3 SRX366168 | NCI-H441 Lung | 350 / 18006 (1.9%) | 11342 / 180060 (6.3%) | −159.2 | −157.2 | 0.31 |
| FOXA1 SRX3923516 | MCF-7 Breast | 286 / 18006 (1.6%) | 10248 / 180060 (5.7%) | −159.0 | −157.0 | 0.28 |
| JUND SRX190303 | HCT 116 Digestive tract | 517 / 18006 (2.9%) | 14000 / 180060 (7.8%) | −158.9 | −157.0 | 0.37 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 503 / 18006 (2.8%) | 13778 / 180060 (7.7%) | −158.9 | −156.9 | 0.37 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 393 / 18006 (2.2%) | 12026 / 180060 (6.7%) | −158.6 | −156.6 | 0.33 |
| ESR1 SRX330067 | MCF-7 Breast | 372 / 18006 (2.1%) | 11669 / 180060 (6.5%) | −158.2 | −156.2 | 0.32 |
| ESR1 SRX20282940 | MCF-7 Breast | 453 / 18006 (2.5%) | 12963 / 180060 (7.2%) | −157.8 | −155.9 | 0.35 |
| ESR1 SRX20282955 | MCF-7 Breast | 443 / 18006 (2.5%) | 12795 / 180060 (7.1%) | −157.6 | −155.6 | 0.35 |
| FOXA1 SRX5203303 | MCF-7 Breast | 121 / 18006 (0.7%) | 7089 / 180060 (3.9%) | −157.5 | −155.5 | 0.17 |
| NR3C1 SRX10977372 | A549 Lung | 223 / 18006 (1.2%) | 9076 / 180060 (5.0%) | −157.5 | −155.5 | 0.25 |
| AR SRX9109110 | MDA-MB-453 Breast | 780 / 18006 (4.3%) | 17814 / 180060 (9.9%) | −157.1 | −155.2 | 0.44 |
| ESR1 SRX10365532 | MCF-7 Breast | 221 / 18006 (1.2%) | 9013 / 180060 (5.0%) | −156.5 | −154.6 | 0.25 |
| GATA3 SRX6712581 | MCF-7 Breast | 338 / 18006 (1.9%) | 11054 / 180060 (6.1%) | −156.5 | −154.6 | 0.31 |
| AR SRX9469988 | LAPC-4 Prostate | 555 / 18006 (3.1%) | 14482 / 180060 (8.0%) | −156.3 | −154.4 | 0.38 |
| ELF3 SRX1389380 | CFPAC-1 Pancreas | 478 / 18006 (2.7%) | 13296 / 180060 (7.4%) | −156.2 | −154.3 | 0.36 |
| ESR1 SRX2881002 | MCF-7 Breast | 395 / 18006 (2.2%) | 11977 / 180060 (6.7%) | −156.2 | −154.2 | 0.33 |
| SMARCC1 SRX10859413 | BT-549 Breast | 447 / 18006 (2.5%) | 12809 / 180060 (7.1%) | −156.1 | −154.1 | 0.35 |
| CEBPB SRX2194247 | SUM 159PT Breast | 341 / 18006 (1.9%) | 11084 / 180060 (6.2%) | −156.0 | −154.1 | 0.31 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 378 / 18006 (2.1%) | 11683 / 180060 (6.5%) | −155.6 | −153.6 | 0.32 |
| STAT1 SRX22524750 | 2fTGH-U6A Others | 332 / 18006 (1.8%) | 10906 / 180060 (6.1%) | −155.2 | −153.2 | 0.30 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 726 / 18006 (4.0%) | 16965 / 180060 (9.4%) | −155.1 | −153.2 | 0.43 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 731 / 18006 (4.1%) | 17032 / 180060 (9.5%) | −155.0 | −153.1 | 0.43 |
| YAP1 SRX1038944 | IMR-90 Lung | 143 / 18006 (0.8%) | 7467 / 180060 (4.1%) | −154.8 | −152.9 | 0.19 |
| SMARCA4 SRX5982340 | A549 Lung | 156 / 18006 (0.9%) | 7724 / 180060 (4.3%) | −154.7 | −152.7 | 0.20 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 387 / 18006 (2.1%) | 11790 / 180060 (6.5%) | −154.5 | −152.6 | 0.33 |
| Epitope tags SRX15939724 | RD Muscle | 355 / 18006 (2.0%) | 11251 / 180060 (6.2%) | −154.1 | −152.1 | 0.32 |
| NR3C1 SRX10977357 | A549 Lung | 246 / 18006 (1.4%) | 9379 / 180060 (5.2%) | −153.8 | −151.9 | 0.26 |
| GATAD2A SRX2636506 | Hep G2 Liver | 536 / 18006 (3.0%) | 14101 / 180060 (7.8%) | −153.8 | −151.8 | 0.38 |
| NR2F2 SRX190293 | MCF-7 Breast | 442 / 18006 (2.5%) | 12633 / 180060 (7.0%) | −153.4 | −151.5 | 0.35 |
| GFP SRX6949256 | HeLa Uterus | 461 / 18006 (2.6%) | 12926 / 180060 (7.2%) | −153.3 | −151.3 | 0.36 |
| FOXA1 SRX11222438 | MCF-7 Breast | 217 / 18006 (1.2%) | 8834 / 180060 (4.9%) | −153.1 | −151.2 | 0.25 |
| ESR1 SRX371475 | BT-474 Breast | 210 / 18006 (1.2%) | 8696 / 180060 (4.8%) | −152.9 | −150.9 | 0.24 |
| CEBPA SRX2630241 | Hep G2 Liver | 517 / 18006 (2.9%) | 13775 / 180060 (7.7%) | −152.8 | −150.8 | 0.38 |
| ESR1 SRX20282953 | MCF-7 Breast | 344 / 18006 (1.9%) | 11024 / 180060 (6.1%) | −152.6 | −150.7 | 0.31 |
| ESR1 SRX20282946 | MCF-7 Breast | 250 / 18006 (1.4%) | 9408 / 180060 (5.2%) | −152.4 | −150.5 | 0.27 |
| NR3C1 SRX10977373 | A549 Lung | 217 / 18006 (1.2%) | 8790 / 180060 (4.9%) | −151.8 | −149.9 | 0.25 |
| ESR1 SRX20282971 | MCF-7 Breast | 420 / 18006 (2.3%) | 12226 / 180060 (6.8%) | −151.8 | −149.8 | 0.34 |
| RELA SRX7054617 | HAEC Cardiovascular | 501 / 18006 (2.8%) | 13490 / 180060 (7.5%) | −151.6 | −149.7 | 0.37 |
| CEBPB SRX7807101 | Unclassified Unclassified | 302 / 18006 (1.7%) | 10280 / 180060 (5.7%) | −151.5 | −149.6 | 0.29 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1451 / 18006 (8.1%) | 26570 / 180060 (14.8%) | −151.2 | −149.2 | 0.55 |
| DDIT3 SRX11379510 | Liposarcoma, Myxoid Adipocyte | 558 / 18006 (3.1%) | 14332 / 180060 (8.0%) | −150.9 | −149.0 | 0.39 |
| Epitope tags SRX5877913 | U2OS Bone | 2246 / 18006 (12.5%) | 36395 / 180060 (20.2%) | −150.9 | −149.0 | 0.62 |
| ESR1 SRX330069 | MCF-7 Breast | 259 / 18006 (1.4%) | 9512 / 180060 (5.3%) | −150.8 | −148.9 | 0.27 |
| ARID1A SRX5089382 | MCF-7 Breast | 291 / 18006 (1.6%) | 10066 / 180060 (5.6%) | −150.8 | −148.9 | 0.29 |
| ESR1 SRX371474 | BT-474 Breast | 193 / 18006 (1.1%) | 8315 / 180060 (4.6%) | −150.7 | −148.8 | 0.23 |
| FOS SRX4677295 | CFPAC-1 Pancreas | 233 / 18006 (1.3%) | 9042 / 180060 (5.0%) | −150.5 | −148.5 | 0.26 |
| BRD4 SRX2194271 | SUM 159PT Breast | 1125 / 18006 (6.2%) | 22283 / 180060 (12.4%) | −150.4 | −148.5 | 0.50 |
| ESR1 SRX5323873 | MCF-7 Breast | 524 / 18006 (2.9%) | 13794 / 180060 (7.7%) | −150.4 | −148.5 | 0.38 |
| ESR1 SRX2943589 | MCF-7 Breast | 212 / 18006 (1.2%) | 8656 / 180060 (4.8%) | −150.3 | −148.4 | 0.24 |
| FOXA1 SRX028635 | MCF-7 Breast | 207 / 18006 (1.1%) | 8554 / 180060 (4.8%) | −150.1 | −148.2 | 0.24 |
| FOXA2 SRX3230382 | Hep G2 Liver | 582 / 18006 (3.2%) | 14655 / 180060 (8.1%) | −150.0 | −148.1 | 0.40 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 180 / 18006 (1.0%) | 8050 / 180060 (4.5%) | −150.0 | −148.1 | 0.22 |
| ZEB1 SRX13298924 | MCF-7 Breast | 193 / 18006 (1.1%) | 8291 / 180060 (4.6%) | −150.0 | −148.1 | 0.23 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 166 / 18006 (0.9%) | 7777 / 180060 (4.3%) | −150.0 | −148.1 | 0.21 |
| AR SRX9109113 | MDA-MB-453 Breast | 811 / 18006 (4.5%) | 17967 / 180060 (10.0%) | −149.9 | −148.0 | 0.45 |
| ARID1A SRX5089391 | MCF-7 Breast | 228 / 18006 (1.3%) | 8933 / 180060 (5.0%) | −149.9 | −148.0 | 0.26 |
| JUN SRX699737 | HCASMC Cardiovascular | 271 / 18006 (1.5%) | 9693 / 180060 (5.4%) | −149.8 | −147.9 | 0.28 |
| SS18 SRX10881848 | G-401 Kidney | 568 / 18006 (3.2%) | 14439 / 180060 (8.0%) | −149.8 | −147.9 | 0.39 |
| PGR SRX1012655 | MCF-7 Breast | 268 / 18006 (1.5%) | 9636 / 180060 (5.4%) | −149.7 | −147.8 | 0.28 |
| NR3C1 SRX19024866 | MCF-7 Breast | 135 / 18006 (0.7%) | 7154 / 180060 (4.0%) | −149.6 | −147.7 | 0.19 |
| MAU2 SRX15710569 | RPE Neural | 405 / 18006 (2.2%) | 11908 / 180060 (6.6%) | −149.6 | −147.7 | 0.34 |
| FOXA1 SRX3931033 | MCF-7 Breast | 263 / 18006 (1.5%) | 9539 / 180060 (5.3%) | −149.5 | −147.6 | 0.28 |
| ESR1 SRX2881000 | MCF-7 Breast | 379 / 18006 (2.1%) | 11487 / 180060 (6.4%) | −149.4 | −147.5 | 0.33 |
| JUNB SRX2443774 | A549 Lung | 171 / 18006 (0.9%) | 7855 / 180060 (4.4%) | −149.3 | −147.4 | 0.22 |
| ZEB1 SRX13298923 | MCF-7 Breast | 168 / 18006 (0.9%) | 7795 / 180060 (4.3%) | −149.3 | −147.4 | 0.22 |
| FOXA1 SRX5203307 | MCF-7 Breast | 109 / 18006 (0.6%) | 6601 / 180060 (3.7%) | −149.2 | −147.3 | 0.17 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 140 / 18006 (0.8%) | 7234 / 180060 (4.0%) | −149.0 | −147.1 | 0.19 |
| SREBF2 SRX5359048 | HCC70 Breast | 1690 / 18006 (9.4%) | 8126 / 180060 (4.5%) | −148.9 | −147.0 | 2.08 |
| FOSL2 SRX10475404 | A549 Lung | 209 / 18006 (1.2%) | 8546 / 180060 (4.7%) | −148.6 | −146.7 | 0.24 |
| CEBPB SRX190308 | HCT 116 Digestive tract | 395 / 18006 (2.2%) | 11716 / 180060 (6.5%) | −148.5 | −146.7 | 0.34 |
| Epitope tags SRX5877911 | U2OS Bone | 2081 / 18006 (11.6%) | 34273 / 180060 (19.0%) | −148.3 | −146.4 | 0.61 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 627 / 18006 (3.5%) | 15251 / 180060 (8.5%) | −148.2 | −146.3 | 0.41 |
| ESR1 SRX330070 | MCF-7 Breast | 218 / 18006 (1.2%) | 8691 / 180060 (4.8%) | −148.0 | −146.1 | 0.25 |
| GFP SRX5417098 | HeLa Uterus | 500 / 18006 (2.8%) | 13338 / 180060 (7.4%) | −147.9 | −146.0 | 0.37 |
| CEBPB SRX7807103 | Adipocytes Adipocyte | 391 / 18006 (2.2%) | 11629 / 180060 (6.5%) | −147.9 | −146.0 | 0.34 |
| FOXA1 SRX15430999 | T-47D Breast | 475 / 18006 (2.6%) | 12949 / 180060 (7.2%) | −147.8 | −145.9 | 0.37 |
| YAP1 SRX10119363 | MCF 10A Breast | 172 / 18006 (1.0%) | 7826 / 180060 (4.3%) | −147.7 | −145.8 | 0.22 |
| EP300 SRX717859 | HeLa Uterus | 219 / 18006 (1.2%) | 8695 / 180060 (4.8%) | −147.5 | −145.6 | 0.25 |
| EP300 SRX1012648 | MCF-7 Breast | 202 / 18006 (1.1%) | 8384 / 180060 (4.7%) | −147.5 | −145.6 | 0.24 |
| STAT3 SRX8520800 | SUM 159PT Breast | 261 / 18006 (1.4%) | 9439 / 180060 (5.2%) | −147.4 | −145.5 | 0.28 |
| Epitope tags SRX15939725 | RD Muscle | 324 / 18006 (1.8%) | 10512 / 180060 (5.8%) | −147.4 | −145.5 | 0.31 |
| SMARCC1 SRX11379526 | Liposarcoma, Myxoid Adipocyte | 335 / 18006 (1.9%) | 10694 / 180060 (5.9%) | −147.3 | −145.4 | 0.31 |
| GATA3 SRX100559 | T-47D Breast | 475 / 18006 (2.6%) | 12928 / 180060 (7.2%) | −147.2 | −145.4 | 0.37 |
| ZEB1 SRX13298925 | MCF-7 Breast | 259 / 18006 (1.4%) | 9395 / 180060 (5.2%) | −147.1 | −145.2 | 0.28 |
| FOXA1 SRX5323845 | MCF-7 Breast | 146 / 18006 (0.8%) | 7294 / 180060 (4.1%) | −146.9 | −145.0 | 0.20 |
| SOX13 SRX2636248 | Hep G2 Liver | 589 / 18006 (3.3%) | 14642 / 180060 (8.1%) | −146.9 | −145.0 | 0.40 |
| FOXA1 SRX190181 | A549 Lung | 308 / 18006 (1.7%) | 10222 / 180060 (5.7%) | −146.7 | −144.8 | 0.30 |
| RELA SRX7054657 | HAEC Cardiovascular | 481 / 18006 (2.7%) | 12999 / 180060 (7.2%) | −146.6 | −144.7 | 0.37 |
| FOXA1 SRX3923519 | MCF-7 Breast | 258 / 18006 (1.4%) | 9358 / 180060 (5.2%) | −146.6 | −144.7 | 0.28 |
| EP300 SRX717860 | HeLa Uterus | 269 / 18006 (1.5%) | 9549 / 180060 (5.3%) | −146.5 | −144.6 | 0.28 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 286 / 18006 (1.6%) | 9838 / 180060 (5.5%) | −146.4 | −144.5 | 0.29 |
| BRD4 SRX736204 | 90-8TL Neural | 906 / 18006 (5.0%) | 3114 / 180060 (1.7%) | −146.3 | −144.4 | 2.91 |
| JUN SRX883585 | MDA-MB-231 Breast | 506 / 18006 (2.8%) | 13367 / 180060 (7.4%) | −146.2 | −144.3 | 0.38 |
| WWTR1 SRX10119370 | MCF 10A Breast | 248 / 18006 (1.4%) | 9168 / 180060 (5.1%) | −146.0 | −144.1 | 0.27 |
| SMARCA4 SRX5982341 | A549 Lung | 122 / 18006 (0.7%) | 6783 / 180060 (3.8%) | −146.0 | −144.1 | 0.18 |
| IKZF1 SRX2424551 | GM12878 Blood | 785 / 18006 (4.4%) | 17430 / 180060 (9.7%) | −145.8 | −143.9 | 0.45 |
| EP300 SRX22550927 | CDS1 Bone | 649 / 18006 (3.6%) | 15480 / 180060 (8.6%) | −145.7 | −143.8 | 0.42 |
| AGO2 SRX6783957 | Hep G2 Liver | 1191 / 18006 (6.6%) | 4854 / 180060 (2.7%) | −145.6 | −143.8 | 2.45 |
| EP300 SRX11470503 | Mesenchymal stem cells Others | 455 / 18006 (2.5%) | 12561 / 180060 (7.0%) | −145.6 | −143.7 | 0.36 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 287 / 18006 (1.6%) | 9827 / 180060 (5.5%) | −145.5 | −143.7 | 0.29 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 211 / 18006 (1.2%) | 8490 / 180060 (4.7%) | −145.5 | −143.7 | 0.25 |
| CEBPB SRX3584202 | Epididymis Gonad | 396 / 18006 (2.2%) | 11621 / 180060 (6.5%) | −145.4 | −143.6 | 0.34 |
| ASPSCR1 SRX17321275 | ASPS1 Lung | 725 / 18006 (4.0%) | 16568 / 180060 (9.2%) | −145.4 | −143.6 | 0.44 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 287 / 18006 (1.6%) | 9825 / 180060 (5.5%) | −145.4 | −143.5 | 0.29 |
| EP300 SRX1012644 | MCF-7 Breast | 190 / 18006 (1.1%) | 8094 / 180060 (4.5%) | −145.3 | −143.4 | 0.23 |
| MethylCap SRX014766 | NB-4 Blood | 1568 / 18006 (8.7%) | 7364 / 180060 (4.1%) | −145.2 | −143.3 | 2.13 |
| FOXL2 SRX5342375 | SVOG-3e Gonad | 329 / 18006 (1.8%) | 10522 / 180060 (5.8%) | −145.2 | −143.3 | 0.31 |
| CEBPA SRX4705113 | MOLM-13 Blood | 985 / 18006 (5.5%) | 20165 / 180060 (11.2%) | −145.1 | −143.2 | 0.49 |
| SMARCA4 SRX10859410 | BT-549 Breast | 869 / 18006 (4.8%) | 18566 / 180060 (10.3%) | −144.8 | −143.0 | 0.47 |
| STAT5B SRX831881 | CD8+ T cells Blood | 241 / 18006 (1.3%) | 155 / 180060 (0.1%) | −144.2 | −142.3 | 15.55 |
| FOXA1 SRX5203294 | MCF-7 Breast | 113 / 18006 (0.6%) | 6541 / 180060 (3.6%) | −144.2 | −142.3 | 0.17 |
| ESR1 SRX20282938 | MCF-7 Breast | 352 / 18006 (2.0%) | 10862 / 180060 (6.0%) | −144.0 | −142.2 | 0.32 |
| STAT3 SRX4192888 | MCF 10A Breast | 214 / 18006 (1.2%) | 8492 / 180060 (4.7%) | −143.9 | −142.0 | 0.25 |
| LMNA SRX3962742 | BJ-5ta Epidermis | 602 / 18006 (3.3%) | 14719 / 180060 (8.2%) | −143.9 | −142.0 | 0.41 |
| NKX2-1 SRX366170 | NCI-H441 Lung | 326 / 18006 (1.8%) | 10426 / 180060 (5.8%) | −143.7 | −141.8 | 0.31 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 150 / 18006 (0.8%) | 7278 / 180060 (4.0%) | −143.7 | −141.8 | 0.21 |
| AGO2 SRX6783958 | Hep G2 Liver | 1169 / 18006 (6.5%) | 4751 / 180060 (2.6%) | −143.6 | −141.8 | 2.46 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 441 / 18006 (2.4%) | 807 / 180060 (0.4%) | −143.6 | −141.8 | 5.46 |
| ESR1 SRX1531796 | MCF-7 Breast | 231 / 18006 (1.3%) | 8786 / 180060 (4.9%) | −143.6 | −141.7 | 0.26 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 510 / 18006 (2.8%) | 13327 / 180060 (7.4%) | −143.5 | −141.7 | 0.38 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 607 / 18006 (3.4%) | 14778 / 180060 (8.2%) | −143.5 | −141.6 | 0.41 |
| JUND SRX186637 | SK-N-SH Neural | 306 / 18006 (1.7%) | 10079 / 180060 (5.6%) | −143.4 | −141.5 | 0.30 |
| SMARCA4 SRX5982364 | A549 Lung | 131 / 18006 (0.7%) | 6890 / 180060 (3.8%) | −143.2 | −141.4 | 0.19 |
| TLE3 SRX4815193 | SUM 149PT Breast | 444 / 18006 (2.5%) | 12303 / 180060 (6.8%) | −143.2 | −141.3 | 0.36 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 162 / 18006 (0.9%) | 7493 / 180060 (4.2%) | −143.1 | −141.2 | 0.22 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 512 / 18006 (2.8%) | 13341 / 180060 (7.4%) | −143.0 | −141.2 | 0.38 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 579 / 18006 (3.2%) | 14344 / 180060 (8.0%) | −142.9 | −141.1 | 0.40 |
| FOXA1 SRX3923515 | MCF-7 Breast | 239 / 18006 (1.3%) | 8908 / 180060 (4.9%) | −142.9 | −141.0 | 0.27 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 223 / 18006 (1.2%) | 8609 / 180060 (4.8%) | −142.4 | −140.6 | 0.26 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1035 / 18006 (5.7%) | 20724 / 180060 (11.5%) | −142.4 | −140.6 | 0.50 |
| TP53 SRX3102569 | SW 480 Digestive tract | 839 / 18006 (4.7%) | 18039 / 180060 (10.0%) | −142.2 | −140.3 | 0.47 |
| Epitope tags SRX11051013 | hTERT RPE-1 Neural | 379 / 18006 (2.1%) | 11234 / 180060 (6.2%) | −142.1 | −140.2 | 0.34 |
| RAD21 SRX150650 | HeLa Uterus | 592 / 18006 (3.3%) | 14502 / 180060 (8.1%) | −142.0 | −140.2 | 0.41 |
| ARID5B SRX10475139 | Hep G2 Liver | 476 / 18006 (2.6%) | 12756 / 180060 (7.1%) | −142.0 | −140.2 | 0.37 |
| ESR1 SRX10365533 | MCF-7 Breast | 207 / 18006 (1.1%) | 8305 / 180060 (4.6%) | −142.0 | −140.1 | 0.25 |
| RELA SRX7054661 | HAEC Cardiovascular | 700 / 18006 (3.9%) | 16067 / 180060 (8.9%) | −141.9 | −140.1 | 0.44 |
| EP300 SRX1521303 | ZR-75-30 Breast | 321 / 18006 (1.8%) | 10278 / 180060 (5.7%) | −141.9 | −140.1 | 0.31 |
| NANOG SRX10445309 | Neural crest cells Neural | 239 / 18006 (1.3%) | 8875 / 180060 (4.9%) | −141.8 | −140.0 | 0.27 |
| CEBPB SRX4394545 | SU-DHL-1 Bone | 432 / 18006 (2.4%) | 12060 / 180060 (6.7%) | −141.7 | −139.9 | 0.36 |
| ESR1 SRX3110725 | MCF-7 Breast | 403 / 18006 (2.2%) | 11595 / 180060 (6.4%) | −141.5 | −139.7 | 0.35 |
| ESR1 SRX3123829 | MCF-7 Breast | 254 / 18006 (1.4%) | 9122 / 180060 (5.1%) | −141.3 | −139.4 | 0.28 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 424 / 18006 (2.4%) | 11917 / 180060 (6.6%) | −141.2 | −139.4 | 0.36 |
| ESR1 SRX1469949 | MCF-7 Breast | 255 / 18006 (1.4%) | 9114 / 180060 (5.1%) | −140.5 | −138.7 | 0.28 |
| NR3C1 SRX19024870 | MCF-7 Breast | 141 / 18006 (0.8%) | 7005 / 180060 (3.9%) | −140.4 | −138.5 | 0.20 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 418 / 18006 (2.3%) | 11789 / 180060 (6.5%) | −140.3 | −138.4 | 0.35 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 363 / 18006 (2.0%) | 10912 / 180060 (6.1%) | −140.2 | −138.4 | 0.33 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1606 / 18006 (8.9%) | 7745 / 180060 (4.3%) | −140.1 | −138.3 | 2.07 |
| RAD21 SRX9005642 | OVCAR-8 Gonad | 1283 / 18006 (7.1%) | 23891 / 180060 (13.3%) | −140.1 | −138.3 | 0.54 |
| FOSL2 SRX8616829 | A549 Lung | 450 / 18006 (2.5%) | 12273 / 180060 (6.8%) | −139.8 | −138.0 | 0.37 |
Showing first 500 of 19366 rows.